A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2023-03-31
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2023-07-27 (study day 105); relationship: N
mild
assessed
Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-09-13 (study day 153); relationship: N
mild
assessed
Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-10-11 (study day 181); relationship: not assessed
mild
assessed
Grade 1 Vomiting — outcome: RECOVERED/RESOLVED; onset 2024-01-13 (study day 275); relationship: not assessed
Data queries
No data queries.